PMID: 9059966Feb 1, 1997

Cholestasis associated with mesalazine therapy in a patient with Crohn's disease

Journal of Hepatology
B StoschusT Sauerbruch

Abstract

Mesalazine is a widely prescribed medication, developed as an alternative to sulfasalazine in the treatment of inflammatory bowel disease. In contrast to sulfasalazine, there are only a few case reports on its causing hepatic injury. We here report on a patient with cholestasis after mesalazine therapy for Crohn's disease of the ileum. The patient, a 30-year-old man, developed clinical signs of severe hepatic injury 4 months after treatment with mesalazine (4 g/day) including biopsy-proven hepatocellular cholestasis with minimal focal mononuclear inflammatory infiltration. Contrary to previous reports, no symptoms of generalized hypersensitivity were seen. The patient's illness was resolved by discontinuing the mesalazine treatment and he recovered completely in 40 days. This case reinforces the possibility of a causal relationship between mesalazine treatment and toxic hepatic injury without systemic hypersensitivity.

References

Jun 16, 1978·JAMA : the Journal of the American Medical Association·A A MihasR L Slaughter
Mar 10, 1990·Lancet·K S KristensenS Friis
Jan 1, 1990·Scandinavian Journal of Gastroenterology. Supplement·R Brimblecombe
Mar 15, 1989·Annals of Internal Medicine·B SachedinaJ Whittey
Nov 11, 1989·BMJ : British Medical Journal·D K Woodward
Aug 19, 1989·Lancet·P DeprezR Fiasse
Apr 1, 1987·Scandinavian Journal of Gastroenterology·S S RaoC D Holdsworth
Mar 15, 1985·Biochemical Pharmacology·R HaasL A Eguren
Aug 1, 1983·British Journal of Clinical Pharmacology·M J DewJ Rhodes
Jan 1, 1983·British Journal of Clinical Pharmacology·J Feely, A J Wood

Citations

Mar 4, 2010·Inflammatory Bowel Diseases·Udayakumar Navaneethan, Bo Shen
Jul 26, 2003·Clinics in Liver Disease·Cynthia Levy, Keith D Lindor
Apr 5, 2012·Gastroenterology Research and Practice·Victor UkoKadakkal Radhakrishnan
May 7, 2014·Journal of Pharmacology & Pharmacotherapeutics·Giovanni Clemente ActisFloriano Rosina
Jul 16, 1999·The American Journal of Gastroenterology·M BraunR Tur-Kaspa
Jun 27, 2015·BMJ Case Reports·Teresa StelzerLudwig Theodor Heuss
Dec 9, 2015·World Journal of Hepatology·Robert HirtenDavid E Bernstein
Apr 4, 2002·Alimentary Pharmacology & Therapeutics·R N Cunliffe, B B Scott
Jul 17, 2020·Current Gastroenterology Reports·Michele S BarnhillJames H Lewis

Related Concepts

Aminosalicylic Acids
Analgesics, Anti-Inflammatory
Cholestasis
IIeocolitis
Novo-5 ASA

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners
J R KlausL C Knodel
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
Phunchai Charatcharoenwitthaya, Keith D Lindor
© 2021 Meta ULC. All rights reserved